LAINDON MEDICAL GROUP — All Prescriptions & Medications — Page 8
Practice Code: F81108 | BASILDON, SS15 5TR
Showing results 351-400 of 627
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Ciprofloxacin | 54 | 1,955 | £292 | +35.4% ▲ |
| Terbinafine hydrochloride | 54 | 2,442 | £1.1K | -12.6% ▼ |
| Valaciclovir | 54 | 4,324 | £5.6K | +284.3% ▲ |
| Hepatitis A | 54 | 54 | £1.1K | -28.9% ▼ |
| 54 | 141 | £1.1K | +74.1% ▲ | |
| Mebeverine hydrochloride compound preparations | 53 | 3,850 | £3.4K | +368.8% ▲ |
| Oxytetracycline | 53 | 7,336 | £3.1K | +105.2% ▲ |
| 53 | 135 | £506 | +30.2% ▲ | |
| 53 | 810 | £2.7K | +72.5% ▲ | |
| Salmeterol | 52 | 75 | £2.2K | +116.2% ▲ |
| Naratriptan hydrochloride | 52 | 456 | £88 | +98.9% ▲ |
| 52 | 946 | £408 | +20.6% ▲ | |
| Amiodarone hydrochloride | 51 | 2,415 | £128 | -20.9% ▼ |
| Carvedilol | 50 | 3,724 | £104 | -55.9% ▼ |
| Co-trimoxazole(Trimethoprim/sulfamethoxazole) | 50 | 2,336 | £178 | +24.5% ▲ |
| Anastrozole | 50 | 2,520 | £93 | -45.1% ▼ |
| RtS 2-2.4 kcal/ml m/sk higher protein,higher energy(0913011) | 50 | 398.6K | £4.5K | +14.3% ▲ |
| Diclofenac sodium | 50 | 3,737 | £193 | -1.5% vs avg |
| Piroxicam | 50 | 6,388 | £166 | -13.0% ▼ |
| Sennosides | 49 | 20.5K | £389 | +58.7% ▲ |
| Hyoscine hydrobromide | 49 | 1,558 | £267 | +43.5% ▲ |
| 49 | 860 | £1.6K | +49.3% ▲ | |
| 49 | 2,410 | £8.3K | +327.9% ▲ | |
| Calcium carbonate | 48 | 5,018 | £480 | -27.1% ▼ |
| Midazolam hydrochloride | 48 | 372 | £209 | +17.3% ▲ |
| Primidone | 46 | 3,660 | £4.8K | +29.3% ▲ |
| Midodrine hydrochloride | 45 | 6,480 | £1.5K | -7.6% ▼ |
| Dutasteride | 44 | 2,566 | £146 | -14.3% ▼ |
| Benzoyl peroxide | 44 | 2,910 | £498 | +212.2% ▲ |
| 44 | 333 | £293 | +323.5% ▲ | |
| Sodium picosulfate | 43 | 12.2K | £1.0K | +18.5% ▲ |
| Lofepramine hydrochloride | 43 | 4,060 | £1.7K | +43.7% ▲ |
| Heparinoid | 43 | 3,500 | £266 | +229.7% ▲ |
| Other toiletry preparations | 43 | 20.8K | £290 | +0.7% vs avg |
| Dicycloverine hydrochloride | 42 | 6,556 | £6.8K | +254.8% ▲ |
| Aclidinium bromide/formoterol | 42 | 48 | £1.5K | +19.5% ▲ |
| Guanfacine | 42 | 1,176 | £2.3K | +63.5% ▲ |
| Nefopam hydrochloride | 42 | 3,672 | £155 | -62.9% ▼ |
| Celecoxib | 42 | 3,404 | £164 | -36.4% ▼ |
| Rabeprazole sodium | 41 | 511 | £58 | -20.5% ▼ |
| Nitrazepam | 41 | 1,884 | £99 | -21.1% ▼ |
| Haloperidol | 41 | 3,065 | £3.2K | -13.9% ▼ |
| Dexamethasone | 41 | 2,018 | £324 | +31.5% ▲ |
| Cabergoline | 41 | 512 | £907 | +164.4% ▲ |
| Duloxetine hydrochloride | 41 | 1,988 | £464 | -20.0% ▼ |
| 41 | 378 | £549 | -40.1% ▼ | |
| Enoxaparin | 40 | 1,260 | £5.1K | +95.2% ▲ |
| Mycophenolate mofetil | 40 | 5,778 | £960 | -1.2% vs avg |
| Fenofibrate | 39 | 2,776 | £366 | -59.7% ▼ |
| Levocetirizine | 39 | 2,010 | £259 | +150.3% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.